Welcome to CDC stacks | Opportunities for Merging Chemical and Biological Synthesis - 30147 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Opportunities for Merging Chemical and Biological Synthesis
Filetype[PDF-723.60 KB]


Details:
  • Pubmed ID:
    24747284
  • Pubmed Central ID:
    PMC4199929
  • Description:
    Organic chemists and metabolic engineers use largely orthogonal technologies to access small molecules like pharmaceuticals and commodity chemicals. As the use of biological catalysts and engineered organisms for chemical production grows, it is becoming increasingly evident that future efforts for chemical manufacture will benefit from the integration and unified expansion of these two fields. This review will discuss approaches that combine chemical and biological synthesis for small molecule production. We highlight recent advances in combining enzymatic and non-enzymatic catalysis in vitro, discuss the application of design principles from organic chemistry for engineering non-biological reactivity into enzymes, and describe the development of biocompatible chemistry that can be interfaced with microbial metabolism.

  • Document Type:
  • Collection(s):
  • Funding:
    DP2 GM105434/DP/NCCDPHP CDC HHS/United States
    DP2 GM105434/GM/NIGMS NIH HHS/United States
No Related Documents.
You May Also Like: